Putin: Russia is about to develop a cancer vaccine

According to Reuters on February 14th, Russian President Putin said today that Russian scientists are close to developing a cancer vaccine that will soon be available for use by patients.

Putin said in a televised speech, "We are very close to developing so-called cancer vaccines and a new generation of immunomodulatory drugs."

He gave a speech at a forum in Moscow on future technology. He also said, "I hope they will soon be effectively used as individual treatment methods."

Putin did not specify which type of cancer this vaccine will prevent, nor did he explain how to prevent it.

According to reports, many countries and companies are researching cancer vaccines.

Last year, the UK government signed an agreement with Biotech, headquartered in Germany, to launch clinical trials offering personalized cancer treatments, with the goal of benefiting 10000 patients by 2030.

Modena and Merck, two pharmaceutical companies, are developing an experimental cancer vaccine. A mid-term study showed that after 3 years of treatment, this vaccine can reduce the recurrence or mortality rate of melanoma, a deadly skin cancer, by half.

According to data from the World Health Organization, there are currently six licensed vaccines targeting human papillomavirus (HPV), which can cause many cancers including cervical cancer, as well as some vaccines targeting hepatitis B virus (HBV), which may lead to liver cancer.

During the COVID-19, Russia developed its own COVID-19 vaccine "Satellite-V".

Putin himself said that he had received the "satellite" vaccine to demonstrate its effectiveness and safety to people.